Ticker Short Interest

LYEL Short Interest Intelligence

Lyell Immunopharma Inc positioning pressure, squeeze risk, bearish conviction, crowding, days to cover, and price-positioning divergence.

Latest settlement 30 Jun 2026 Neutral

Neutral

Bearish Exhaustion Watch

LYEL is classified as Neutral. Latest reported short interest is 1.2M shares; short interest changed -7.1%, price moved -14.0% since the previous report, short interest is in the 29th percentile, and days to cover is in the 14th percentile. Trend context is weak.

Setup Score40/100Neutral
Reported Short Interest1.2M-7.1% vs prior report
Days To Cover3.4414.29 percentile
Price Reaction-14.0%since previous short report
Squeeze Pressure11crowding, trend, and pressure
Bearish Conviction40shorts adding into weakness

Reported Short Interest

2026-03-31 to 2026-06-30

Days To Cover

liquidity pressure

Short Interest Change

report-to-report

Price Context

2026-03-20 to 2026-06-26

Squeeze Radar

11

Elevated short interest becomes most interesting when price strength forces shorts to defend or cover.

Bearish Conviction

40

Rising short interest alongside weak trend can mean the bearish trade is being reinforced, not trapped.

Crowding

22

Latest short interest is 1.2M shares and days to cover is 3.44.

Divergence

32

Short interest fell while price fell. Shorts are covering despite weak price action, which can suggest the easy bearish pressure may be fading.

Report History

LYEL Short Interest Ledger

Most recent first
SettlementShort interestPreviousChangeDays coverAverage volume
30 Jun 2026 1223220 1316562 -7.1% 3.44 355339
15 Jun 2026 1316562 1353275 -2.7% 9.62 136926
29 May 2026 1353275 1340406 1.0% 16.21 83489
15 May 2026 1340406 1344189 -0.3% 23.25 57657
30 Apr 2026 1344189 1234370 8.9% 18.78 71577
15 Apr 2026 1234370 1138296 8.4% 12.04 102547
31 Mar 2026 1138296 940269 21.1% 12.78 89076

Short interest is delayed, reported on a periodic schedule, and may be revised. The dashboard is research context only and does not prove real-time short activity.